These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25023403)

  • 21. Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery.
    Li H; Tang K; Niu L; Liang Y; Li J; Chen J; Xu K
    Cancer Biomark; 2013; 13(5):337-43. PubMed ID: 24440973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Onitsuka T
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):244-7. PubMed ID: 22897792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of serum carcinoembryonic antigen in predicting responses to chemotherapy and survival in patients with non-small cell lung cancer.
    Liu H; Gu X; Lv T; Wu Y; Xiao Y; Yuan D; Li Y; Song Y
    J Cancer Res Ther; 2014; 10(2):239-43. PubMed ID: 25022372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer.
    Niklinski J; Furman M; Laudanski J; Kozlowski M
    Eur J Cancer Prev; 1992 Oct; 1(6):401-6. PubMed ID: 1334443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study.
    Arrieta O; Villarreal-Garza C; Martínez-Barrera L; Morales M; Dorantes-Gallareta Y; Peña-Curiel O; Contreras-Reyes S; Macedo-Pérez EO; Alatorre-Alexander J
    BMC Cancer; 2013 May; 13():254. PubMed ID: 23697613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.
    Cho A; Hur J; Hong YJ; Lee HJ; Kim YJ; Hong SR; Suh YJ; Im DJ; Kim YJ; Lee JS; Shim HS; Choi BW
    Tumour Biol; 2016 Mar; 37(3):3205-13. PubMed ID: 26432331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
    Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
    Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer: external validation of a prognostic score.
    Blankenburg F; Hatz R; Nagel D; Ankerst D; Reinmiedl J; Gruber C; Seidel D; Stieber P
    Tumour Biol; 2008; 29(4):272-7. PubMed ID: 18781099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis.
    Arrieta O; Saavedra-Perez D; Kuri R; Aviles-Salas A; Martinez L; Mendoza-Posada D; Castillo P; Astorga A; Guzman E; De la Garza J
    BMC Cancer; 2009 Apr; 9():119. PubMed ID: 19386089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study.
    Yamashita J; Matsuo A; Kurusu Y; Saishoji T; Hayashi N; Ogawa M
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):299-305. PubMed ID: 12167790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
    Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
    Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
    Dal Bello MG; Filiberti RA; Alama A; Orengo AM; Mussap M; Coco S; Vanni I; Boccardo S; Rijavec E; Genova C; Biello F; Barletta G; Rossi G; Tagliamento M; Maggioni C; Grossi F
    J Transl Med; 2019 Mar; 17(1):74. PubMed ID: 30849967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.
    Jiang R; Wang X; Li K
    Oncotarget; 2016 May; 7(18):26823-36. PubMed ID: 27072585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Significance of Serum CEA for Non-small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy.
    Shintani T; Matsuo Y; Iizuka Y; Mitsuyoshi T; Mizowaki T; Hiraoka M
    Anticancer Res; 2017 Sep; 37(9):5161-5167. PubMed ID: 28870949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum CEA level change and its significance before and after Gefitinib therapy on patients with advanced non-small cell lung cancer.
    Qin HF; Qu LL; Liu H; Wang SS; Gao HJ
    Asian Pac J Cancer Prev; 2013; 14(7):4205-8. PubMed ID: 23991977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
    Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J
    J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CEA, CYFRA21-1 and SCC in non-small cell lung cancer.
    Moro D; Villemain D; Vuillez JP; Delord CA; Brambilla C
    Lung Cancer; 1995 Oct; 13(2):169-76. PubMed ID: 8581396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
    Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.